Rami Levin

Rami Levin is a seasoned biotech executive with nearly 30 years of experience in the pharmaceutical and biotechnology industries. He managed businesses with large P&Ls, has taken businesses through scale ups and fast growth. Led private and public companies and managed VC owned companies and has raised substantial and transformational capital. Rami served as the Chief Executive Officer of ImStem Biotechnology, a clinical stage biotechnology company focused on stem cell research and development of treatments targeting autoimmune, degenerative, and rare orphan diseases. Prior to joining ImStem Biotechnology Rami was the President and Chief Executive Officer of Saniona, a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for rare disease patients. Prior to joining Saniona, Rami served as President of Sobi Inc., the North American affiliate of international rare disease company Sobi. At Sobi, Rami was a member of the Executive team of the company. He built and led the North American organization from infancy to a team of over 300 employees generating over half a billion USD in annual revenue. Prior to joining Sobi, Rami held commercial leadership roles of increasing strategic importance for over 16 years at Merck Serono in several countries, including the U.S., Sweden, Switzerland and Israel and prior to that at Schering AG.

Rami Levin is also the founder and CEO of The Outcomes Group, a strategy and corporate development consulting group. Rami is a strategic consultant and corporate development expert, with a certification is business and executive coaching. Rami specialises in helping pharmaceutical and biotech executives accelerate and amplify their results, identify and overcome obstacles to enhance their performance and contribute to the growth of their companies.